INR 42.57
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 724.23 Million INR | 10.1% |
2022 | 657.79 Million INR | 26.35% |
2021 | 520.59 Million INR | 19.95% |
2020 | 434.01 Million INR | 79.97% |
2019 | 241.15 Million INR | 52.91% |
2018 | 157.71 Million INR | 25.13% |
2017 | 126.03 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q4 | 724.23 Million INR | 10.91% |
2023 FY | 724.23 Million INR | 10.1% |
2023 Q2 | 653 Million INR | -0.73% |
2022 Q4 | 657.79 Million INR | 12.02% |
2022 Q2 | 587.22 Million INR | 12.8% |
2022 FY | 657.79 Million INR | 26.35% |
2021 FY | 520.59 Million INR | 19.95% |
2021 Q2 | 462.93 Million INR | 6.66% |
2021 Q4 | 520.59 Million INR | 12.45% |
2020 Q2 | 295.3 Million INR | 22.46% |
2020 FY | 434.01 Million INR | 79.97% |
2020 Q4 | 434.01 Million INR | 46.97% |
2019 Q4 | 241.15 Million INR | 19.93% |
2019 FY | 241.15 Million INR | 52.91% |
2019 Q2 | 201.08 Million INR | 27.5% |
2018 FY | 157.71 Million INR | 25.13% |
2018 Q4 | 157.71 Million INR | 21.01% |
2018 Q2 | 130.32 Million INR | 3.4% |
2017 FY | 126.03 Million INR | 0.0% |
2017 Q4 | 126.03 Million INR | 34.74% |
2017 Q2 | 93.54 Million INR | 23.15% |
2016 Q4 | 75.95 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.36 Billion INR | 46.978% |
Biocon Limited | 307.95 Billion INR | 99.765% |
Blue Jet Healthcare Limited | 2.13 Billion INR | 66.098% |
Concord Biotech Limited | 1.74 Billion INR | 58.392% |
Dishman Carbogen Amcis Limited | 39.53 Billion INR | 98.168% |
FERMENTA BIOTECH LIMITED | 2.62 Billion INR | 72.428% |
GENOMIC VALLEY BIOTECH LIMITED | 7.91 Million INR | -9048.86% |
Lyka Labs Limited | 884.58 Million INR | 18.127% |
Panacea Biotec Limited | 4.02 Billion INR | 81.985% |
SAMSRITA LABS LIMITED | 32.93 Million INR | -2098.983% |
Servoteach Industries Limited | 5275.00 INR | -13729473.46% |
SMS Lifesciences India Limited | 1.96 Billion INR | 63.215% |
Supriya Lifescience Limited | 1.05 Billion INR | 31.592% |
Syngene International Limited | 18.93 Billion INR | 96.176% |
TAKE Solutions Limited | 969.78 Million INR | 25.32% |
Titan Biotech Limited | 231.28 Million INR | -213.133% |
Transgene Biotek Limited | 393.11 Million INR | -84.232% |